Concurrent/sequential versus sequential immune checkpoint inhibition in inoperable large stage III non-small cell lung cancer patients treated with chemoradiotherapy: a prospective observational study

PURPOSE/AIM: The international standard for patients with large inoperable stage III NSCLC is durvalumab consolidation after concurrent chemoradiotherapy (CRT). In this single centre observational study based on individual data, we prospectively evaluated the role of concurrent/sequential versus seq...

Descripción completa

Detalles Bibliográficos
Autores principales: Käsmann, Lukas, Eze, Chukwuka, Taugner, Julian, Nieto, Alexander, Hofstetter, Kerstin, Kröninger, Sophie, Guggenberger, Julian, Kenndoff, Saskia, Flörsch, Benedikt, Tufman, Amanda, Reinmuth, Niels, Duell, Thomas, Belka, Claus, Manapov, Farkhad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374706/
https://www.ncbi.nlm.nih.gov/pubmed/36939927
http://dx.doi.org/10.1007/s00432-023-04654-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374706/
https://www.ncbi.nlm.nih.gov/pubmed/36939927
http://dx.doi.org/10.1007/s00432-023-04654-w

Ejemplares similares